This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
REDWOOD CITY, Calif.,
Nov. 10, 2011 /PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that
Bernard A. Hausen, M.D., Ph.D., the company's president and chief executive officer, is scheduled to present a corporate overview and update at the following conferences:
8th Annual Lazard Capital Markets Healthcare ConferenceTuesday, November 15, 20118:00 a.m. ETNew York, NY
23rd Annual Piper Jaffray Healthcare ConferenceTuesday, November 29, 20119:30 a.m.New York, NY
To access the live and subsequently archived webcasts of the presentations, go to the Investor Relations section of the company's website at
http://www.cardica.com/. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System, for coronary artery bypass graft (CABG) surgery and has shipped over 37,000 units throughout the world. In addition, Cardica is developing the Cardica MicroCutter XPRESS™ 30, a true multi-fire laparoscopic stapling device designed to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter products require 510(k) review and are not yet commercially available in the U.S.
SOURCE Cardica, Inc.